Conclusions
It is clear that unless the surgeon is specially committed to a study of breast cancer, he or she no longer can hope to have the necessary knowledge of the wide variety of techniques now required for the investigation and treatment of this disease. Since women with breast tumors often seek the advice of the surgeon as a first step, it is essential that it be realized that surgery is only part of the management of the patient. Nevertheless, the surgeon must be fully aware of the principles underlying the investigation and planned therapy of women with malignancies of the breast. In this review we have attempted to present a summary of new developments and likely trends for the future.
References
British Breast Group: Systemic chemotherapy in early breast cancer. Br. Med. J.2:861, 1976
Paterson, R., Russel, M.H.: Clinical trials in malignant disease: II-Breast cancer: value of irradiation of the ovaries. J. Fac. Radiol.10:130, 1959
Cole, M.P.: Suppression of ovarian function in primary breast cancer. In Prognostic Factors in Breast Cancer, A.P.M. Forrest and P.B. Kunkler, editors. London, E & S Livingstone, 1968, p. 146
Nissen-Meyer, R.: Suppression of ovarian function in primary breast cancer. In Prognostic Factors in Breast Cancer, A.P.M. Forrest and P.B. Kunkler, editors. London, E & S Livingstone, 1968, p. 139
Rights and permissions
About this article
Cite this article
Forrest, A.P.M., Maureen Roberts, M. Progress in the treatment of breast cancer—Introduction. World J. Surg. 1, 281–283 (1977). https://doi.org/10.1007/BF01556837
Issue Date:
DOI: https://doi.org/10.1007/BF01556837